Insiders Updates
Analysts predict EYPT shares will perform strongly in 2023
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its
The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also